Myocardial Contractile Reserve by Dobutamine Stress Echocardiography Predicts Improvement in Ejection Fraction with β-Blockade in Patients with Heart Failure: The β-Blocker Evaluation of Survival Trial (BEST)

Circulation

Volumn 108, Issue 19, 2003, Pages 2336-2341

  Eichhorn, Eric J ^a,h   Grayburn, Paul A ^a   Mayer, Susan A ^a   Sutton, Martin St John ^b   Appleton, Christopher ^c   Plehn, Jonathan ^d   Oh, Jae ^e   Greenberg, Barry ^f   DeMaria, Anthony ^f   Frantz, Robert ^e   Krause Steinrauf, Heidi ^d,g  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MAYO CLINIC   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^h Cardiopulmonary Research Science and Technology Institute   (United States)

Author keywords

Bucindolol; Contractility; Heart failure; Norepinephrine; Receptors, adrenergic, beta

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUCINDOLOL; DOBUTAMINE; NORADRENALIN; PLACEBO;

ADRENERGIC ACTIVITY; ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MOVEMENT; HEART MUSCLE CONTRACTILE FORCE; HEART RIGHT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; SCINTISCANNING; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NOREPINEPHRINE; PROPANOLAMINES; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 0242442134     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000097111.00170.7B     Document Type: Article

References (26)

1. Eichhorn EJ, Bristow MR. Medical therapy can improve the biologic properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation. 1996;94:2285-2296.
2. Eichhorn EJ, Heesch CM, Barnett JH, et al. Effect of metoprolol on myocardial function and energetics in Patients with non-ischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1994;24:1310-1320.
3. Hall SA, Cigarroa CG, Marcoux L, et al. Time course of improvement in left ventricular function, mass, and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol. 1995;25:1154-1161.
4. Tsutsui H, Spinale FG, Nagatsu M, et al. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest. 1994;93:2639-2648.
5. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9-13.
6. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
7. Packer M, Coats AJS, Fowler MB, et al, for the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658.
8. Lechat P, Escolano S, Golmard JL, et al, on behalf of the CIBIS Investigators. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation. 1997;96:2197-2205.
9. The BEST Investigators. A trial of the beta-adrenergic blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344:1659-1667.
10. Eichhorn EJ, Heesch CM, Risser RC, et al. Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol. J Am Coll Cardiol. 1995;25:154-162.
11. deFilippi CR, Willett DL, Irani WN, et al. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation. 1995;92:2863-2868.
12. Cigarroa CG, deFilippi CR, Brickner ME, et al. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation. 1993;88:430-436.
13. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-367.
14. Dehmer GJ, Lewis SE, Hillis LD, et al. Nongeometric determination of left ventricular volumes from equilibrium blood pool scans. Am J Cardiol. 1980;45:293-300.
15. Clavell A, Stingo A, Aarhus L, et al. Biological actions of BNP in thoracic inferior vena caval constriction. Am J Physiol. 1993;265: R1416-R1422.
16. Lowes BD, Gilbert EM, Abraham WT, et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med. 2002;346:1357-1365.
17. Weber KT, Anversa P, Armstrong PW, et al. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol. 1992;20:3-16.
18. Yamada T, Fukunami M, Ohmori M, et al. Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint. J Am Coll Cardiol. 1993;21:628-633.
19. Sabbah HN, Sharov VG, Gupta RC, et al. Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure. J Am Coll Cardiol. 2000;36:1698-1705.
20. Bohm M, Deutsch HJ, Hartmann D, et al. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure. J Am Coll Cardiol. 1997;30:992-996.
21. Cintron G, Johnson G, Francis G, et al. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation. 1993;87(suppl VI):VI-17-VI-23.
22. Eichhorn EJ, Domanski M, Adams K, et al, for the BEST Investigators. Effect of β-blockade on mortality in African-Americans: the β-Blocker Evaluation of Survival Trial. Circulation. 2000;102(suppl II):II-778.
23. Coats AJS. Heart Failure 99: the MOXCON story. Int J Cardiol. 1999;71:109-111.
24. Afridi I, Grayburn PA, Panza JA, et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol. 1998;32:921-926.
25. Cornel JH, Bax JJ, Elhendy A, et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease. J Am Coll Cardiol. 1998;31:1002-1010.
26. Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol. 1997;29:1234-1240.